50 Years of Global Health Progress Report
This report traces global health progress over the past 50 years. It reviews some of the research-based biopharmaceutical industry’s major scientific advances, as well as acknowledging challenges the industry faces and areas of unfinished business.
Read more
Continuing progress in global health: Working together for the future – IFPMA Flagship Event @WHA71
On the occasion of its 50th anniversary, IFPMA invites you to join an event where mutiple stakeholders will be coming together to discuss the enablers of health progress over the past fifty years, and what is needed to ensure continued progress going forward.
Details and RSVP
Global Code Comparison
An overview of the global R&D-based biopharmaceutical industry’s self-regulation mechanisms and the commitment of IFPMA members to ethical promotion and interactions for the safety and benefit of patients worldwide.
Read More
AMR Industry Alliance
Together with 100+ companies and trade associations from the AMR Industry Alliance, IFPMA is committed to stop superbugs. Check out our first Progress Report!
Read More
A #mustwatch - our event @WHA71 - click under resources
Have a full detail on one of our events organized at the margins of WHA71.
Read More
IFPMA Corporate Brochure - Committed to a Healthier Future
We hope you find this brochure informative to gain better understanding of the contributions of our industry. We are passionate about the role we play in finding effective and sustainable solutions to today’s most pressing health concerns and look forward to continuing the dialogue with our partners
Read More
IFPMA HEALTH PARTNERSHIPS DIRECTORY
IFPMA hosts the Health Partnerships Directory, a continuously expanding online database that allows users to view, in depth, health partnerships from across the world that involve the research-based biopharmaceutical industry.
Read MoreIFPMA in Brief
IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.
Tackling Global health challenges
The research-based biopharmaceutical industry is proud to be playing its part in the quest to find effective and sustainable solutions to today’s most pressing health concerns.
Read More
Boosting Innovation and Access
The research-based biopharmaceutical industry is thinking creatively about its innovation and business models to meet new challenges, and is working in collaboration with different players from the scientific community.
Read More
Strengthening Regulatory Systems
Patients everywhere should be treated with high quality medicines and vaccines. Science-based guidelines provide direction for the development, manufacture, and supply of medicines.
Read More
Building trust
The healthcare community and the public must be confident that research-based biopharmaceutical industry and their employees, wherever they operate, communicate and act in an ethical and professional manner.
Read More
Discovering medicines and Vaccines
Never have people lived longer and never have so many children been saved from dying in the first years of life. Medicines and vaccines extend and improve the quality of life for many people.
Read More
Our Resources
The Globalisation of the Pharmaceutical Industry
Read More
IFPMA & IFPW Supply chain session 2016 Global Health Forum - long version
The session that took place at 2016 GHF ‘Shaping a sound supply chain ecosystem’ gathered speakers from BMS, IFPW Walgreens Boots Alliance, ICRC and WHO. Moderated by Scrip’s Sukaina Virji. To find out more about the complexities of the pharmaceutical supply chain, to hear what experts think are the essential...
Read More
IFPMA Welcomes Set-Up of New African Medicines Agency
Geneva, 25 May 2018 – To mark Africa Day, soon after African health ministers of 55-country African Union, all gathered at the 71st World Health Assembly, unanimously adopted a treaty to establish the African Medicines Agency, IFPMA seizes this momentum to welcome this important milestone. The new African Medicines Agency...
Read More
IFPMA @DIAEurope
Read More
ABPI, EFPIA, and IFPMA issue joint statement on AMR
ABPI, EFPIA and IFPMA issue joint statement following publication of the final report by the Review on AMR The Association of the British Pharmaceutical Industry (ABPI), the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) have today issued a joint...
Read More
Join IFPMA
Our membership has three levels tailored to meet specific needs. Full Members have to be R&D-based pharmaceutical companies or national associations whose membership includes innovative pharmaceutical companies; Associate Members of R&D-based pharmaceutical companies and national associations whose permanent staff numbers are less than five, and Affiliate Members that are organizations, associations, companies and institutions who are supportive of the R&D-based
LEARN MOREOur Blog
Opinion: Beware of fake news on global health
This blog was first published on Devex on 23 May 2018 At the 2014 Nobel Laureate Meeting in Lindau, Germany, the late Professor Hans Rosling quizzed his audience of leading scientists on average life expectancy. Given three choices, just over a quarter of the crowd picked the correct answer of 70. That’s fewer than would be likely randomly. It is reassuring that even eminent...
Read More
@WorldIPDay: Women working their magic on innovation in health
Every April 26, we celebrate World Intellectual Property Organization’s (WIPO) World Intellectual Property Day to recognize the role that intellectual property (IP) rights play in encouraging innovation and creativity. This year’s campaign celebrates the brilliance, ingenuity, curiosity and courage of the women who are driving change in our world and shaping our common future. I have dedicated my career in academia, government and industry to promoting health and...
Read More
Vaccines: Vital in fighting antimicrobial resistance
This blog was first published on EPM on 23 April 2018. We have been lucky to live through a period of improving global public health, facilitated in part by innovation from and partnerships with the pharmaceutical industry. However we now find ourselves facing a new threat from an old foe – infectious disease through antimicrobial resistance (AMR). The challenge ahead is extensive but this World...
Read MoreLatest Tweets
@IFPMA @IFPMA @IFPMA @IFPMA @IFPMA 